ITGB1 and plasma cell myeloma: As shown in Figure 3, the second generation of MSCs of multiple myeloma showed no expression of surface markers of hematopoietic cells, such as CD34 and CD45, and displayed low expression of CD106, high expression of CD29, and the surface markers of MSCs (CD105).